NO20071880L - Diagnostic Compounds - Google Patents

Diagnostic Compounds

Info

Publication number
NO20071880L
NO20071880L NO20071880A NO20071880A NO20071880L NO 20071880 L NO20071880 L NO 20071880L NO 20071880 A NO20071880 A NO 20071880A NO 20071880 A NO20071880 A NO 20071880A NO 20071880 L NO20071880 L NO 20071880L
Authority
NO
Norway
Prior art keywords
diagnostic compounds
processes
diagnostic
compounds
radiopharmaceuticals
Prior art date
Application number
NO20071880A
Other languages
English (en)
Norwegian (no)
Inventor
Magne Solbakken
Alan Cuthbertson
Bente E Arbo
Alexander Gibson
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20071880L publication Critical patent/NO20071880L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20071880A 2004-09-14 2007-04-13 Diagnostic Compounds NO20071880L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
PCT/IB2005/002727 WO2006030291A2 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
NO20071880L true NO20071880L (no) 2007-06-13

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071880A NO20071880L (no) 2004-09-14 2007-04-13 Diagnostic Compounds

Country Status (24)

Country Link
US (2) US7875701B2 (ru)
EP (1) EP1791571B1 (ru)
JP (1) JP4949251B2 (ru)
KR (1) KR101243016B1 (ru)
CN (1) CN101151054B (ru)
AT (1) ATE404225T1 (ru)
AU (1) AU2005283904B8 (ru)
BR (1) BRPI0515175A (ru)
CA (1) CA2578470C (ru)
DE (1) DE602005008996D1 (ru)
DK (1) DK1791571T3 (ru)
ES (1) ES2312018T3 (ru)
GB (1) GB0420344D0 (ru)
HK (1) HK1118713A1 (ru)
IL (1) IL181529A (ru)
MX (1) MX2007003019A (ru)
NO (1) NO20071880L (ru)
NZ (1) NZ553384A (ru)
PL (1) PL1791571T3 (ru)
PT (1) PT1791571E (ru)
RU (1) RU2396272C9 (ru)
SI (1) SI1791571T1 (ru)
WO (1) WO2006030291A2 (ru)
ZA (1) ZA200702700B (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2452923C (en) * 2001-07-10 2012-02-07 Amersham Health As Peptide-based compounds for targeting integrin receptors
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
AU2007294685B2 (en) 2006-09-15 2012-06-07 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
WO2008072976A2 (en) * 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
EP2125039A2 (en) 2006-12-18 2009-12-02 GE Healthcare AS Synthesis of a radiofluorinated peptide using photolabile protecting groups
EP2114464A2 (en) * 2006-12-28 2009-11-11 GE Healthcare AS Radiofluorination methods
AU2007348145A1 (en) * 2007-03-01 2008-09-04 Bayer Schering Pharma Aktiengesellschaft 18F fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers
JP5318874B2 (ja) * 2007-09-10 2013-10-16 ジーイー・ヘルスケア・リミテッド 放射性フッ素化方法
US8415510B2 (en) 2008-02-28 2013-04-09 Ge Healthcare Limited Synthesis of a PEG-6 moiety from commercial low-cost chemicals
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
WO2011084763A1 (en) 2009-12-21 2011-07-14 Ge Healthcare Limited Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
KR20130119957A (ko) 2010-12-01 2013-11-01 지이 헬쓰케어 리미티드 방사성 접합 방법
JP6055417B2 (ja) * 2010-12-09 2016-12-27 ジーイー・ヘルスケア・リミテッド 放射性トレーサー組成物
NZ612151A (en) * 2010-12-21 2015-08-28 Ge Healthcare Ltd Use of aniline in the radiostabilization of oxime ligation
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
RU2719399C2 (ru) 2014-12-04 2020-04-17 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ удаления ацетальдегида из радиоактивных фармацевтических препаратов
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2452923C (en) 2001-07-10 2012-02-07 Amersham Health As Peptide-based compounds for targeting integrin receptors
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
CA2578470A1 (en) 2006-03-23
SI1791571T1 (sl) 2009-02-28
PL1791571T3 (pl) 2009-01-30
BRPI0515175A (pt) 2008-07-08
AU2005283904A1 (en) 2006-03-23
WO2006030291A3 (en) 2007-06-14
JP4949251B2 (ja) 2012-06-06
US20110117016A1 (en) 2011-05-19
ES2312018T3 (es) 2009-02-16
MX2007003019A (es) 2007-08-07
KR20070053750A (ko) 2007-05-25
US20080095701A1 (en) 2008-04-24
EP1791571A2 (en) 2007-06-06
HK1118713A1 (en) 2009-02-20
GB0420344D0 (en) 2004-10-13
AU2005283904B2 (en) 2012-01-19
CA2578470C (en) 2015-09-01
US7875701B2 (en) 2011-01-25
DE602005008996D1 (de) 2008-09-25
NZ553384A (en) 2011-02-25
ZA200702700B (en) 2008-09-25
CN101151054A (zh) 2008-03-26
EP1791571B1 (en) 2008-08-13
PT1791571E (pt) 2008-11-19
ATE404225T1 (de) 2008-08-15
RU2396272C9 (ru) 2010-12-10
RU2396272C2 (ru) 2010-08-10
KR101243016B1 (ko) 2013-03-12
JP2008516894A (ja) 2008-05-22
WO2006030291A2 (en) 2006-03-23
DK1791571T3 (da) 2008-12-08
RU2007108762A (ru) 2008-10-27
IL181529A (en) 2015-04-30
US8563600B2 (en) 2013-10-22
CN101151054B (zh) 2014-09-24
IL181529A0 (en) 2007-07-04
AU2005283904B8 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
NO20071880L (no) Diagnostic Compounds
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
AR110056A2 (es) Modulación de receptores quimiosensoriales y ligandos relacionados con los mismos
CR10157A (es) Compuestos químicos
ME01992B (me) Jedinjenje diarilhidantoina
EA201070786A1 (ru) Бензофуропиримидиноны
CR11861A (es) Compuestos organicos
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
RS53003B (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
EA200702352A1 (ru) Новые композиции нутрицевтиков
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CY1115919T1 (el) Ενωσεις ενεργοποιησης τελομερασης και μεθοδοι χρησης αυτων
DE602006009789D1 (de) Acetylenderivate
WO2009035959A3 (en) Radiofluorination methods
UY30788A1 (es) Compuestos quimicos
CY1110891T1 (el) Παραγωγα 6-ετεροαρυλπυριδοϊνδολονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη
WO2008083191A3 (en) Radiofluorination methods
RS53747B1 (en) FENANTRENON UNITS, COMPOSITIONS AND METHODS
EA200702590A1 (ru) Ингибиторы растворимой аденилатциклазы
EA200870565A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение
NI200700232A (es) Uso de un compuesto
EA200870566A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензотиазепины, их получение, композиции, содержащие их, и применение

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA